Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Massachusetts, Worcester
With
University of Connecticut
Northeastern University
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)
Age
50–100
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
History of Transient Ischemic Attack (TIA) or stroke or at risk for stroke based on a CHA2DS2-VASc score equal to or greater to a score of 3, presenting at the UMass Memorial Medical Center (UMMMC) inpatient service or ambulatory clinic (neurology clinics and cardiovascular clinics included)
Age: greater to or equal to 50 years of age
Able to sign informed consent
Willing to participant in a focus groups and/or Hack-a-thon for Aim 1 participants only
Willing and capable of using Pulsewatch (smartwatch and smartphone app) daily for up to 44-days and returning to UMMMC for up to two study visits for Aims 2 and 3 participants only
You may not be if
Major contraindication to anti-coagulation treatment
Plans to move our of the area over the 44-day follow up period
Serious physical illness (e.g., unable to interact with a smart device, or communicate verbally or via written text) that would interfere with study participation
Known allergies or hypersensitivities to medical grade hydrocolloid adhesives or hydrogel
Patient with life threatening arrhythmia's who require in-patient monitoring for immediate analysis
Patient with implantable pacemaker as paced beats interfere with ECG readings
Lacking capacity to sign informed consent
Unable to read and write in English
Plans to move from the area during the study period
Unwilling to complete all study procedures
Major contraindication to anti-coagulation treatment (i.e., major hemorrhagic stroke)
